Chart Series: At What Cost?: Egregious Price Increases in the Pharmaceutical Drug Industry
The charts in this gallery were used by the Joint Economic Committee during the hearing entitled, "At What Cost?: Egregious Price Increases in the Pharmaceutical Drug Industry"
« Previous Page
Page 1 of 1
Next Page »
Huge Drug Price Increases
Rare Hodgkins Lymphoma Drug Price
Pharmaceutical Companies Earn Higher ProfitsThan Other Fortune 500 Firms
Extraordinary Price Increases are Becoming More Common
The President says his policies are working to make the economy strong and that all Americans are benefiting, but the facts show an economic record that has left the vast majority of American families behind. All charts are kept current using the most up-to-date economic data.
The JEC has compiled a timeline of events tracking the subprime crisis from December 2006 to the present. Although it does not include every event in the markets, in Congress, or in the Administration, it provides a fairly comprehensive background guide to the current housing crisis and the steps taken to avoid further deterioration of the subprime market.